Form 4: Standard BioTools CEO Michael Egholm Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Michael Egholm sold shares of Standard BioTools to cover tax obligations arising from the vesting of restricted stock units.
Summary
- On August 20, 2024, Michael Egholm, the President & CEO and a director of Standard BioTools Inc., sold 29,093 shares of common stock to cover tax obligations.
- The sale was executed at a price of $1.91 per share.
- Following the transaction, Egholm directly owns 1,502,499 shares of Standard BioTools Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations.
Industry Context
This is a routine Form 4 filing related to insider transactions. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of restricted stock units grant to Michael Egholm. |
| 05/21/2024 | Form 4 filed with the U.S. Securities and Exchange Commission reporting the grant of restricted stock units. |
| 08/20/2024 | Date of the transaction where shares were withheld to satisfy tax obligations. |
| 09/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.